Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewGenIvf (NIVF) Current Deferred Revenue (2022 - 2025)

NewGenIvf (NIVF) has disclosed Current Deferred Revenue for 4 consecutive years, with $111981.0 as the latest value for Q4 2025.

  • Quarterly Current Deferred Revenue rose 76.38% to $111981.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $111981.0 through Dec 2025, up 76.38% year-over-year, with the annual reading at $111981.0 for FY2025, 76.38% up from the prior year.
  • Current Deferred Revenue for Q4 2025 was $111981.0 at NewGenIvf, up from $63489.0 in the prior quarter.
  • The five-year high for Current Deferred Revenue was $1.4 million in Q4 2022, with the low at $7937.0 in Q4 2023.
  • Average Current Deferred Revenue over 4 years is $385893.8, with a median of $87735.0 recorded in 2024.
  • The sharpest move saw Current Deferred Revenue tumbled 99.42% in 2023, then soared 699.91% in 2024.
  • Over 4 years, Current Deferred Revenue stood at $1.4 million in 2022, then plummeted by 99.42% to $7937.0 in 2023, then skyrocketed by 699.91% to $63489.0 in 2024, then soared by 76.38% to $111981.0 in 2025.
  • According to Business Quant data, Current Deferred Revenue over the past three periods came in at $111981.0, $63489.0, and $7937.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.